Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00925405 · ClinicalTrials.gov registry record

Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy

A clinical trial, sponsored by M.D. Anderson Cancer Center.

Terminated
Registry status
10
Enrollment target

NCT00925405: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.

NCT00925405 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00925405 was terminated before completion, sponsored by M.D. Anderson Cancer Center.

TERMINATED
Registry status
10 participants
Enrollment target

Study Summary

Objectives: The objective of this single-arm, prospective study is to perform annual mammography and MRI breast cancer screening in women who underwent mantle-field irradiation between 1970-1995 at M. D. Anderson Cancer Center in order to compare the ability of MRI and standard mammography to identify breast cancer. In addition, we will determine whether the combination of breast MRI and mammography identifies smaller, earlier-stage tumors, which would lead to improved cure rates. We will also take the opportunity to determine the incidence and stage of breast cancer in this high-risk cohort.

Interventions

  • PROCEDURE Mammogram
  • PROCEDURE Breast MRI

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2009-06
Est. Completion 2011-10

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT00925405

The ClinicalTrials.gov registry entry for NCT00925405 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Mammogram is the first listed.

NCT00925405 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00925405 about?

NCT00925405 is a clinical study titled "Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy". Objectives: The objective of this single-arm, prospective study is to perform annual mammography and MRI breast cancer screening in women who underwent mantle-field irradiation between 1970-1995 at M. D. Anderson Cancer Center in order to compare the ability of MRI and standard mammography to ident...

What is the current status of trial NCT00925405?

This trial is currently terminated. The enrollment target is 10 participants. The study started on 2009-06. Estimated completion is 2011-10.

What interventions are being tested in trial NCT00925405?

The interventions under investigation include: Mammogram (PROCEDURE), Breast MRI (PROCEDURE).

Who is sponsoring clinical trial NCT00925405?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.